NCT02838927 Survey on Epidemiology of Hypoparathyroidism in France
| NCT ID | NCT02838927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | European Georges Pompidou Hospital |
| Condition | Hypoparathyroidism |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2016-07 |
| Primary Completion | 2030-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2016-07 with a primary completion date of 2030-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.
Eligibility Criteria
Inclusion Criteria: * patient fro whom chronic hypoparathyroidism is diagnosed * patient living in France Exclusion Criteria: * patient who does not want his data to be collected in this registry * pseudo-hypoparathyroidism * acute hypoparathyroidism
Contact & Investigator
Jean-Philippe Bertocchio, MD, PhD
PRINCIPAL INVESTIGATOR
European Georges Pompidou Hospital, APHP
Frequently Asked Questions
Who can join the NCT02838927 clinical trial?
This trial is open to participants of all sexes, studying Hypoparathyroidism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02838927 currently recruiting?
Yes, NCT02838927 is actively recruiting participants. Contact the research team at jpbertocchio@gmail.com for enrollment information.
Where is the NCT02838927 trial being conducted?
This trial is being conducted at Saint-Denis, France, Aix-en-Provence, France, Amiens, France, Auch, France and 11 additional locations.
Who is sponsoring the NCT02838927 clinical trial?
NCT02838927 is sponsored by European Georges Pompidou Hospital. The principal investigator is Jean-Philippe Bertocchio, MD, PhD at European Georges Pompidou Hospital, APHP. The trial plans to enroll 3,000 participants.